semaglutide palpitations GLP-1 Heart Palpitations: Safety, Causes & Management GLP-1 Medications Now Recommended First

physicians and 503A-certified pharmacy partners

Important safety note: Because retatrutide is unlicensed in the UK, there is no MHRA-approved Summary of Product Characteristics or monitoring recommendations for routine clinical use, and there is no regulated supply chain

Studies have shown measurable bone density changes in as little as 12 months of treatment

Severe or bloody diarrhea requires immediate medical attention, as this is not a typical side effect of semaglutide and may indicate infection, inflammatory conditions, or other serious causes

Less muscle means a somewhat lower resting metabolic rate, lower daily energy expenditure, and a smaller margin for error with your diet